The company disclosed preliminary results in mid January, but it left out important metrics such as earnings per share for the fourth quarter.
Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback